Understanding OUR Cytokine-Based Immunotherapy Candidates Our Commitment extends to advancing a robust portfolio of programs geared toward increasing the horizons of cytokine-based immunotherapy, especially for cancers where cure solutions remain limited. Utilize the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline https://financefeeds.com/fiserv-expands-embedded-financial-services-with-payfare-acquisition/